308 results
Page 3 of 16
SC TO-T/A
uu88wfhhjw38
20 Jan 21
Third party tender offer statement (amended)
6:43am
SC TO-T/A
7u4dvv0qjh 2gi
14 Jan 21
Third party tender offer statement (amended)
4:47pm
SC TO-T/A
jcp6m25 rjnz6
5 Jan 21
Third party tender offer statement (amended)
6:45am
SC TO-T
wy1xbofnu6ivwl1
22 Dec 20
Third party tender offer statement
7:07am
8-K
EX-99.1
6ntlaaqk7
15 Dec 20
Lilly Announces 2021 Financial Guidance, Updates 2020 Guidance
7:27am
SC TO-C
3v62m2
15 Dec 20
Information about tender offer
6:29am
8-K
EX-99.1
l1hsdkh93 9ta0v
27 Oct 20
Lilly Reports Third-Quarter Financial Results, Updates Guidance
7:50am
8-K
EX-99.1
2mvkiuq
30 Jul 20
Lilly Reports Second-Quarter Financial Results, Raises EPS Guidance
7:03am
8-K
EX-99.1
2mtt6vq
23 Apr 20
Lilly Reports Strong First-Quarter Financial Results, Adjusts EPS Guidance
8:02am
DEFA14A
yotkhk764gtpzpjxu xa
15 Apr 20
Additional proxy soliciting materials
10:06am
DEFA14A
l5lxqu72
7 Apr 20
Additional proxy soliciting materials
11:46am
DEFA14A
p7s5i52z0y
20 Mar 20
Additional proxy soliciting materials
10:43am
DEFA14A
d5txj3wgcgbvdez
20 Mar 20
Additional proxy soliciting materials
10:40am
SC TO-T/A
9r4gg
20 Feb 20
Third party tender offer statement (amended)
9:12am
SC TO-T/A
9jmkzb2j4 vrntjt9n74
11 Feb 20
Third party tender offer statement (amended)
12:00am
8-K
EX-99.1
m2onoz5cqgegtra67t9
30 Jan 20
Lilly Reports Strong Fourth-Quarter and Full-Year 2019 Financial Results, Updates 2020 Guidance for Pending Dermira Acquisition
6:29am